Evidence map›Paper›PMID 19523448›Full record

ArticleBiochemical and biophysical research communications2009

Minocycline attenuates iron neurotoxicity in cortical cell cultures.

Jing Chen-Roetling, Lifen Chen, Raymond F Regan

Abstract read
In one paragraph

Article in Biochemical and biophysical research communications, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 32 papers.

0numbers the graph read from it
0cells of the map it votes in
32citing papers in PubMed
3.1field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

32 citing papers in PubMed, 61 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Review
  5. Review
  6. Article
  7. Article
  8. Protective effect of vitreous against hemoglobin neurotoxicity.Biochemical and biophysical research communications · 2018
    Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Review
  14. Article
  15. Brain iron overload following intracranial haemorrhage.Stroke and vascular neurology · 2016
    Review
  16. Article
  17. Review
  18. Article
  19. Review
  20. Antioxidants: The new frontier for translational research in cerebroprotection.Journal of anaesthesiology, clinical pharmacology · 2014
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Jing Chen-RoetlingDepartment of Emergency Medicine, Thomas Jefferson University, Philadelphia, PA 19107, USA.
Lifen Chen
Raymond F Regan
Thomas Jefferson University · US

Funding

Effect of Inducible Antioxidants on Hemoglobin ToxicityR01NS042273 · NINDS · THOMAS JEFFERSON UNIVERSITY · PI REGAN, RAYMOND F · 2003 to 2010
$2.7M
NINDS NIH HHS NS042273NINDS NIH HHS R01 NS042273
6 · The paper itself

Abstract

Iron neurotoxicity may contribute to the pathogenesis of intracerebral hemorrhage (ICH). The tetracycline derivative minocycline is protective in ICH models, due putatively to inhibition of microglial activation. Although minocycline also chelates iron, its effect on iron neurotoxicity has not been reported, and was examined in this study. Cortical cultures treated with 10 microM ferrous sulfate for 24h sustained loss of most neurons and an increase in malondialdehyde. Minocycline prevented this injury, with near-complete protection at 30 microM. Two other inhibitors of microglial activation, doxycycline and macrophage/microglia inhibitory factor, were ineffective. Oxidation of isolated culture membranes by iron was also inhibited by minocycline. Consistent with prior observations, minocycline chelated iron in a siderophore colorometric assay; at concentrations less than 100 microM, its activity exceeded that of deferoxamine. These results suggest that attenuation of iron neurotoxicity may contribute to the beneficial effect of minocycline in hemorrhagic stroke and other CNS injury models.

Indexed as

CytoprotectionAnimalsCerebral CortexCerebral HemorrhageDeferoxamineIronIron Chelating AgentsMiceMice, Inbred StrainsMinocyclineNeuronsNeuroprotective AgentsNeurotoxicity SyndromesDeferoxamineIronIron Chelating AgentsMinocyclineNeuroprotective Agents

Identifiers

PMID19523448
PMCPMC2782944
OpenAlexW1978733314

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.